The Ninth Circuit reversed a $40 million jury verdict against XP Power for stealing Comet Technologies’ semiconductor manufacturing trade secrets, finding the district court improperly placed the burden of proof on the defendant.
The Commonwealth Court reversed the Office of Open Records and held that Pennsylvania Lottery ticket VIRN numbers (Validation Information Record Numbers) are trade secrets exempt from Right-to-Know Law disclosure under Section 708(b)(11), even though individual numbers are revealed to winning ticket holders at the time of claiming a prize. The court reasoned that compiling thousands of claimed VIRN numbers produces a recognizable pattern from which Scientific Games’ proprietary validation algorithm could be reconstructed — making the aggregated dataset a trade secret that ‘reveals’ the algorithm even if isolated numbers do not.
Apple filed a blockbuster trade secret lawsuit against OpenAI, io Products, and two former senior Apple engineers, alleging OpenAI systematically recruited Apple employees to steal confidential hardware engineering, manufacturing, and supply chain secrets for its AI device program.
The Fourth Circuit affirmed a preliminary injunction against a Dutch software company’s use of an American company’s brand and trade secrets, holding that Abitron Austria’s conduct-focused test for the territorial reach of U.S. IP law is satisfied where the defendant directly targe
The Fifth Circuit affirmed dismissal of a trade secret misappropriation lawsuit filed by a dissolved Louisiana LLC, holding that under FRCP 17(b)(3) the relevant law is the state where suit is filed—Texas—and Texas law does not allow dissolved entities to bring new claims.
A Northern District of California federal judge partially confirmed an arbitration award protecting Tesla’s dry battery electrode trade secrets, upholding a narrow injunction blocking supplier Matthews International from selling certain battery equipment, while remanding other portions of the award.
The Eighth Circuit affirmed summary judgment for four former employees, holding that Wilbur-Ellis Company’s trade secret claims failed because it never specifically identified what trade secrets were taken or how — and that the coordinated mass departure to a competitor did not, without more,
A Delaware federal judge dismissed Signant Health’s DTSA trade secret claims against Definium Therapeutics, finding that identifying confidential LSD-trial technology only in broad, categorical terms — without pinpointing the specific information allegedly misappropriated — is insufficient to surviv